Study has been confirmed that insulin-like growth factor-binding protein-1 (IGFBP-1) can mediate insulin sensitivity to provide tumor cells with the glucose needed for growth in tumor cells (24). The gene discussed is IGFBPL1; the disease is neoplasm.